Improved biological activity of a mutant endostatin containing a single amino-acid substitution

por Yokoyama, Y, Ramakrishnan, S
Publicado 2004

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients

por Masuya, D, Huang, C, Liu, D, Nakashima, T, Kameyama, K, Haba, R, Ueno, M, Yokomise, H
Publicado 2004

A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer

por Doval, D C, Sekhon, J S, Gupta, S K, Fuloria, J, Shukla, V K, Gupta, S, Awasthy, B S
Publicado 2004

Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer

por Liu, W, Jung, Y D, Ahmad, S A, McCarty, M F, Stoeltzing, O, Reinmuth, N, Fan, F, Ellis, L M
Publicado 2004

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up

por Olivier, R I, van Beurden, M, Lubsen, M A C, Rookus, M A, Mooij, T M, van de Vijver, M J, van't Veer, L J
Publicado 2004

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study

por Feliu, J, Salud, A, Escudero, P, López-Gómez, L, Pericay, C, Castañón, C, de Tejada, M R López, Rodríguez-García, J M, Martínez, M P, Martín, M Sanz, Sánchez, J J, Barón, M González
Publicado 2004

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

por Correale, P, Messinese, S, Caraglia, M, Marsili, S, Piccolomini, A, Petrioli, R, Ceciarini, F, Micheli, L, Nencini, C, Neri, A, Vuolo, G, Guarnieri, A, Abbruzzese, A, Prete, S D, Giorgi, G, Francini, G
Publicado 2004

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling

por Santin, A D, Zhan, F, Bellone, S, Palmieri, M, Cane, S, Gokden, M, Roman, J J, O'Brien, T J, Tian, E, Cannon, M J, Shaughnessy, J, Pecorelli, S
Publicado 2004

Role of protein kinase C and NF-κB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes

por Smith, H J, Wyke, S M, Tisdale, M J
Publicado 2004

Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract

por Hsu, C, Shen, Y-C, Yang, C-H, Yeh, K-H, Lu, Y-S, Hsu, C-H, Liu, H-T, Li, C-C, Chen, J-S, Wu, C-Y, Cheng, A-L
Publicado 2004

Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening

por Duijm, L E M, Groenewoud, J H, Jansen, F H, Fracheboud, J, van Beek, M, de Koning, H J
Publicado 2004

Overexpression of SPARC gene in human gastric carcinoma and its clinic–pathologic significance

por Wang, C-S, Lin, K-H, Chen, S-L, Chan, Y-F, Hsueh, S
Publicado 2004

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer

por Kupryjańczyk, J, Mądry, R, Plisiecka-Hałasa, J, Bar, J, Kraszewska, E, Ziółkowska, I, Timorek, A, Stelmachów, J, Emerich, J, Jędryka, M, Płużańska, A, Rzepka-Górska, I, Urbański, K, Zieliński, J, Markowska, J
Publicado 2004

Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients

por Memon, A A, Sorensen, B S, Melgard, P, Fokdal, L, Thykjaer, T, Nexo, E
Publicado 2004

Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma

por Ogawa, K, Utsunomiya, T, Mimori, K, Tanaka, Y, Tanaka, F, Inoue, H, Murayama, S, Mori, M
Publicado 2004

Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid

por Hettmer, S, McCarter, R, Ladisch, S, Kaucic, K
Publicado 2004

Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model

por Harrington, K J, Syrigos, K N, Uster, P S, Zetter, A, Lewanski, C R, Gullick, W J, Vile, R G, Stewart, J S W
Publicado 2004

Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients

por Comella, P, Frasci, G, Carnicelli, P, Massidda, B, Buzzi, F, Filippelli, G, Maiorino, L, Guida, M, Panza, N, Mancarella, S, Cioffi, R
Publicado 2004

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer

por Chao, Y, Yeh, K H, Chang, C J, Chen, L T, Chao, T Y, Wu, M F, Chang, C S, Chang, J Y, Chung, C Y, Kao, W Y, Hsieh, R K, Cheng, A L
Publicado 2004

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

por Verschuur, A C, Grill, J, Lelouch-Tubiana, A, Couanet, D, Kalifa, C, Vassal, G
Publicado 2004